Prior to founding Ascletis, Dr. Wu was Vice President, global HIV Drug Discovery, GlaxoSmithKline based on Research Triangle Park, NC, with responsibilities ranging from target identification to clinical development.
Before joining GlaxoSmithKline, he was Vice President, Ambrilia Biopharma in Montreal. He was directly responsible for the discovery and development of multiple clinical-stage drugs at Ambrilia.
During his 18 years drug discovery and development career, he also held senior management positions with increasing responsibilities at Immunex/Amgen, Novartis and Aventis.
He received his PhD in Cancer Biology from University of Arizona, Tucson, Arizona, USA.
A member of China National “Thousand Talent Program” .